This guidance has been produced by a multidisciplinary working party on behalf of the UK Chemotherapy Board which includes specialist representation from medical, dental and nursing teams across the UK.

Acute kidney injury (AKI) is a common condition that involves sudden, catastrophic loss of kidney function. It is estimated that AKI is associated with one in five emergency hospital admissions and causes up to 1.7 million deaths globally per year.